Vir Biotechnology, Inc. (NASDAQ: VIR)
$7.5800
-0.0200 ( -0.26% ) 105.1K
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.
Market Data
Open
$7.5800
Previous close
$7.6000
Volume
105.1K
Market cap
$1.04B
Day range
$7.4850 - $7.6950
52 week range
$7.1200 - $13.0900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 26, 2024 |
4 | Insider transactions | 1 | Feb 26, 2024 |
8-k | 8K-related | 17 | Feb 22, 2024 |
8-k | 8K-related | 14 | Feb 20, 2024 |
4 | Insider transactions | 1 | Feb 20, 2024 |
4 | Insider transactions | 1 | Feb 16, 2024 |
4 | Insider transactions | 1 | Jan 03, 2024 |
8-k | 8K-related | 12 | Dec 13, 2023 |
8-k | 8K-related | 12 | Nov 03, 2023 |
10-q | Quarterly Reports | 65 | Nov 03, 2023 |